Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is today's volume/price action the R**N model?
Wow, was the volume only 1400 shares traded today? About $6 worth? Holy cow!
Paid market assassins! I wish I was paid for posting on a message board, it could go towards my college tuition. Anyone believing your posts reflect common sense are foolish enough to believe anything. If I was paid, I would be posting a lot more than I do now. I've got studies to attend to, not silly message board banter. So if you've got no proof of another poster being paid to write negative posts then all you're doing is spewing conspiracy nonsense.
How do you destroy a $0.007 company? As for "being paid," what proof do you have of that being true? How about that?
My guess would be that he's pretty savvy at looking for, and finding, those companies and their managers that seem to be slimy, double-talking, flim-flaming con men. Those folks who operate on the edges of barely legal corporate conduct all the while subverting corporate governance with limited transparency in the hope that no one notices or cares enough to challenge the company's decisions. Company's that are under-represented, singularly controlled and that operate without a vocal and involved BOD. He seems pretty good at it and, I'm only guessing here, that he does so, so others can take a critical look at management and the company's they represent and make critical investment decisions on their own. Whether it's a hobby, an interest of his or maybe he just has the skill set to do this type of work from his past life, I have no idea. I just appreciate his sharing what he knows.
Thank you for the feedback. I will look at the link you referenced but I've been pretty busy lately so it may be awhile, but thanks anyway.
Why would anyone want to invest in a corrupt market?
I'm not so sure if any IPIX shareholder, maybe with the exception of Mr. Ehrlich, would own any part of BeaMed.
My question would be if IPIX has such great results with Brilacidin, then why hasn't a big pharma purchased the drug? Or when those results were published, why IPIX did not pursue a Ph III trial, either by itself or with a partner?
Whatever happened to the lawsuit/dispute over the lease agreement IPIX had with a company in MA? Still pending a legal result?
Thanks for the reply.
Then why invest in IPIX if the deck is stacked against it?
10 years! Wow!
"...starting to worry!" Just now and you're starting to worry? The share price is .0139 for gosh sakes.
"...stop losses many had forgotten about..." Huh?? That's not a theory, that's a shot in the dark.
Stop losses on a .02 stock?
That's something that I've asking, why doesn't BP buy out IPIX if they have a first-in-class drug? I don't buy the reason of "BP is lowballing IPIX." BP didn't buy the compound when the prior company went bankrupt.
Would the drugs provided be approved drugs?
Maybe it's tax loss selling.
Whoever makes the laser it isn't BeaMed because if it were Mr. E would be crowing about it.
"Investor"? or gambler?
If this is such a blockbuster-to-be drug then why hasn't Merck or Gilead Sciences purchased B from IPIX?
Is the 10-K signaling that IPIX is headed towards insolvency?
i.e....no buying...) either.
That's about $2500 worth of the market not giving a rats azz.
You would think that would have happened by now with all of the NIH testing that's been done/completed, the poster presentation etc. So what's the hold up?
And yet, it's a .04 stock.
Is this company going to go bust by the end of 2022?
By my count of the last 15 minutes of the trading day 849,200 shares were traded. Those trades occurred over the 6 minutes during those last 15 minutes of the trading day with 0 trades recorded over the other 9 minutes of the day. If the amount traded over the last 15 minutes were continuous then there may be something to what you are insinuating but because the amounts traded were not sustained throughout the time period, I'm not so sure it means much.
That's because it isn't true. Just made up stuff.
Only four out of the past thirteen weeks have been marked green. The trend may have peaked.
Isn't that a question for big pharma to answer? And so far, after years of testing, Phase II's and accolades by experts only silence from those pharma companies. Why?
"It is the fair price that must be paid for this potential." Fair price? Are you suggesting that BP wouldn't swoop in and pay whatever the valuation may be due to it being the new SOC worth $M/$B dollars? They're quibbling over price? Like I've said many times, money doesn't seem to the issue for BP. So what's the roadblock for BP to own B? It doesn't seem to be money.
Oh, that's an apples-to-apples comparison. SMH
Remember, it's being touted by some as the new SOC drug. What pharma wouldn't want that? Is big pharma that obtuse to have the next $M/$B drug right there for the taking? When a big pharma had made $2.59B on their COVID-19 drug alone you wouldn't think money would be an issue, so assuming money isn't an issue what could it be with all the testing/retesting, the lab successes the Phase II's the company has completed on B? What's the hold up?
"Brilacidin is a game changer. Let no none convince you otherwise." More like a head scratcher, especially so if, "B is safe and effective in over 20 indications."
"Let no one convince you otherwise." I think big pharma needs to be convinced, to own the new SOC drug! What's the hold up? Otherwise people are just shouting into the wind.
"I've not heard of BP pre-announcing deals, so silence is to be expected until..." OK, then how much evidence is needed for BP to decide that B is the $M/$B drug? So BP is taking their time after all of the testing and retesting they have done with B, the experts who have written about the positives of B, the US Government lab results that are said to be positive? A multi-million, or possibly billion dollar new SOC drug needs how much time to convince a big pharma that it's got the goods? You said it yourself, "Brilacidin's scope of indications keeps expanding. We're awaiting publication on about 20 of them. One might surmise that the value of Brilacidin increases with each new indication it's shown to address in reputable third party labs." So what's the hold up? I'm guessing money isn't the issue for BP to acquire B. "The argument that because something hasn't happened yet, it won't happen in the future, makes little sense." Then how gullible do you think people are?